Last reviewed · How we verify
NCT04437732
Apioc Presbyopic Contact Lens
NA trial testing Apioc-P and Apioc-PT Contact Lens Design in Presbyopia in 49 participants. Completed in 9 June 2021.
9 June 2021
Quick facts
| Lead sponsor | Lentechs, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 49 |
| Start date | 11 November 2019 |
| Primary completion | 9 June 2021 |
| Estimated completion | 9 June 2021 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Apioc-P and Apioc-PT Contact Lens Design
Conditions studied
- Presbyopia — all drugs for Presbyopia →
- Refractive Errors — all drugs for Refractive Errors →
Sponsor
Lentechs, LLC
Who can join
Adults 40 to 70, any sex, with Presbyopia or Refractive Errors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, you will wear an invesetigational contact lens, Apioc-P or Apioc-PT, the way you wear your current contact lenses for approximately one month (no more than 35 days).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04437732
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Lentechs, LLC trials
Trials by the same sponsor.
- NCT04883099 — APIOC for Presbyopia and APIOC for Presbyopia With Astigmatism · NA · completed
- NCT04806802 — APIOC Sphere and APIOC Astigmatism · NA · completed
- NCT04031118 — Corneal Oxygen Uptake With Apioc Contact Lenses · NA · completed
- NCT03970512 — Apioc Toric/Spherical Single Vision Contact Lens · NA · completed
- NCT03688672 — Apioc Contact Lens Feasibility · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04437732 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lentechs, LLC
- Last refreshed: 19 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04437732.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing